Business Process Outsourcing
PRODUCTS
-
![GettyImages-1971327276 doctor patient]( "Patient Support And Commercial Services")
Global solutions tailored for your unique needs.
-
![two-business-people-GettyImages-1354841430]( "Qualified Person For Pharmacovigilance (QPPV)")
Gain expert guidance and connect with a global network of qualified QPPVs and LPPVs, who will ensure compliance with pharmacovigilance regulations and tailor their approach to your product launch strategy.
-
![Rare Disease Clinical Trials – The Importance Of Rigorous Study Designs]( "Get Novel Infectious Disease Vaccines, Therapies To Market Faster")
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
![Class 2 Biological Safety Cabinet Type B2]( "Class 2 Biological Safety Cabinet: Type B2")
The Class 2, Type B2 Laminar Flow Biosafety Cabinet provides a high degree of localized protection from particulate and aerosol hazards. The work area is continuously bathed with laminar flow ISO 5/Class 100 HEPA-filtered air while creating a negative pressure airflow into the cabinet to provide user protection.
-
![SpeedAir 3050]( "Enhance Product Safety With A Non-Destructive Leak Testing System")
Versatile CCIT1 for a wide range of applications
The SpeedAir 3050 is your all-in-one solution for nonporous pharmaceutical applications. Whether your products are flexible or rigid, liquid or solid, the SpeedAir 3050 can swiftly and accurately test them all. With testing times as short as 30-45 seconds, it delivers results you can rely on, ensuring the integrity of your pharmaceutical containers.
WHITE PAPERS AND CASE STUDIES
-
![innovation-and-science-concept-istock1177116437-328490833]( "Strategic Clinical Trial Design Unlocks Innovative Funding Opportunity")
Strategic Clinical Trial Design Unlocks Innovative Funding OpportunityA small biotech sponsor developing a new treatment for carcinoma asked for assistance with their trial design. Working with a constrained R&D budget, the challenge was to gather the evidence in a cost-effective manner and use a stage-gate approach for the funding. Explore the solutions uncovered in this case study.
-
![Compliance Regulation Business Technology risk management-GettyImages-1433535736]( "Simplify CAPA In 7 Steps")
Simplify CAPA In 7 StepsDiscover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
![Data Artificial Intelligence Algorithm iStock-1295900106]( "Automated Data Capture To Train An AI Algorithm With eSource")
Automated Data Capture To Train An AI Algorithm With eSourceExplore why an AI algorithm needs a steady and significant stream of data to become more accurate and prove its efficacy in a clinical setting.
-
![Risk GettyImages-519706040]( "Risk Assessment As A Process Quality Assurance Tool")
Risk Assessment As A Process Quality Assurance ToolDiscover how an effective approach to risk management can further ensure the delivery of a high-quality drug or medicine to the patient.
-
![GettyImages-1294319145 breast cancer]( "The Latest Trends In The Prevention And Treatment Of Cervical Cancer")
The Latest Trends In The Prevention And Treatment Of Cervical CancerWhat immune checkpoint inhibitors are showing promise in cervical cancer treatments and how are advancements in treatment, paired with additional prevention strategies, improving patient outcomes?
-
![GettyImages-184960936 fayetteville]( "The City Of Fayetteville's Flood Resiliency In The Face Of Climate Change: Mapping 15 Watersheds")
The City Of Fayetteville's Flood Resiliency In The Face Of Climate Change: Mapping 15 WatershedsThe city of Fayetteville, North Carolina has always had flooding issues, but it’s been getting worse as weather patterns have been changing. They were hit four years in a row by storms Matthew (2016), Irma (2017), Florence (2018), and Dorian (2019).
-
![Embryonic Stem Cells GettyImages-1135352068]( "Using A Fixed Bed Reactor System For Expansion Of Human Embryonic Stem Cells")
Using A Fixed Bed Reactor System For Expansion Of Human Embryonic Stem CellsRegenerative medicine company ViaCyte Inc. explored new technologies to enable expanded scales of culturing hESCs for development of cell replacement therapies as a functional cure for Type 1 diabetes.
-
![cell-line-development]( "Doubling The Speed Of Cell Line Development In A Large Pharmaceutical Company")
Doubling The Speed Of Cell Line Development In A Large Pharmaceutical CompanyWe explore how the Cell Line Development group at Janssen R&D was able to reduce one of their development processes to a single step thanks to new technology.
-
![GettyImages-1180780708 health]( "Benefits Of Implementing EDC & Medical Coding With RTSM")
Benefits Of Implementing EDC & Medical Coding With RTSMDiscover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
![Drug development iStock-1067499066]( "Preparing A New Drug Application (NDA) With A CDISC Conversion")
Preparing A New Drug Application (NDA) With A CDISC ConversionRegulatory submissions are the most critical milestones in clinical research programs. Learn how quality submissions can accelerate time to market, maximize research investments and bring the benefit of new treatments to patients sooner.
-
![GettyImages-1348942302-digitalization-digital-data-information]( "The Digitalization Of Biopharma Process Development, Manufacturing")
The Digitalization Of Biopharma Process Development, ManufacturingThe fourth industrial revolution is coming. Explore the three essentials of bioprocess development and manufacturing digitalization: digital literacy, digital trust, and prioritization.
-
![GettyImages-627646012-planning-collaboration]( "Reimagining FSP With ProPharma's RCO Model")
Reimagining FSP With ProPharma's RCO ModelBegin leveraging our Research Consulting Organization (RCO) model and gain access to customized, agile, and scalable solutions that continuously evolve to meet your unique needs.
NEWS
-
Cancer Drug Discovery Accelerated As Hundreds Of Overlooked Targets Prioritised1/11/2024
A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.
-
Q32 Bio And Homology Medicines Announce Merger Agreement11/16/2023
Q32 Bio Inc., a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Homology Medicines, Inc. (Nasdaq: FIXX), today announced they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.
-
Lenacapavir: Drug Offers New Hope For Multi-Drug Resistant HIV8/29/2023
Onyema Ogbuagu, MD, gets excited about finding new ways to treat HIV—and he is very enthusiastic about lenacapavir, an injection recently approved by the FDA for multi-drug resistant HIV for which he was the principal investigator.
-
The FDA's Proposed Ruling On Lab Tests Could Have Unintended Consequences2/6/2024
Yale experts are raising concerns about a rule proposed by the U.S. Food and Drug Administration (FDA) to enforce the agency’s regulatory control over laboratory-developed tests, or LDTs. The tests play a critical role in filling gaps in commercial testing, such as diagnostic tests for rare diseases deemed unprofitable by manufacturers.
-
eureKING, The First European SPAC In Healthcare Dedicated To Biomanufacturing, Announces The Signature Of A Put Option For The Potential Acquisition Of Skyepharma To Build A New European Bio-CDMO Leader5/30/2023
eureKING (ISIN: FR0014009ON9, Euronext Paris), the first European special purpose acquisition company (“SPAC”) in healthcare dedicated to bioproduction, today announced that it has signed, on May 25, 2023, a put option agreement for 100% of the share capital of Oleron Pharma, the 100% holding company of Skyepharma.